201 related articles for article (PubMed ID: 35977513)
41. Imagenomics. Findings in PET with 68Ga-DOTA-TOC associated with the detection of the mutation of the succinate dehydrogenase B (SDHB) gene in the screening of hereditary pheochromocytoma/paraganglioma.
Ortiz Banguera S; Busquets Carrera O; Ysamat M; Gonzalez JM; Riera Gil E; Garcia JR
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(4):268-270. PubMed ID: 35668017
[No Abstract] [Full Text] [Related]
42. Recent insights into the molecular pathogenesis of pheochromocytoma and paraganglioma.
Nakamura E; Kaelin WG
Endocr Pathol; 2006; 17(2):97-106. PubMed ID: 17159241
[TBL] [Abstract][Full Text] [Related]
43. Models of parent-of-origin tumorigenesis in hereditary paraganglioma.
Hoekstra AS; Devilee P; Bayley JP
Semin Cell Dev Biol; 2015 Jul; 43():117-124. PubMed ID: 26067997
[TBL] [Abstract][Full Text] [Related]
44. Serum Succinate/Fumarate Ratio in Patients With Paraganglioma/Pheochromocytoma Attending an Endocrine Oncogenetic Unit.
Bancel LP; Masso V; Dessein AF; Aubert S; Leteurtre E; Coppin L; Odou MF; Cao CD; Cardot-Bauters C; Pigny P
J Clin Endocrinol Metab; 2023 Aug; 108(9):2343-2352. PubMed ID: 36848172
[TBL] [Abstract][Full Text] [Related]
45. In Vivo Detection of Succinate by Magnetic Resonance Spectroscopy as a Hallmark of SDHx Mutations in Paraganglioma.
Lussey-Lepoutre C; Bellucci A; Morin A; Buffet A; Amar L; Janin M; Ottolenghi C; Zinzindohoué F; Autret G; Burnichon N; Robidel E; Banting B; Fontaine S; Cuenod CA; Benit P; Rustin P; Halimi P; Fournier L; Gimenez-Roqueplo AP; Favier J; Tavitian B
Clin Cancer Res; 2016 Mar; 22(5):1120-9. PubMed ID: 26490314
[TBL] [Abstract][Full Text] [Related]
46. The aggressiveness of succinate dehydrogenase subunit B-deficient chromaffin cells is reduced when their bioelectrical properties are restored by glibenclamide.
Amore F; Garella R; Santi A; Guasti D; Martinelli S; Canu L; Bani D; Neuzil J; Maggi M; Squecco R; Rapizzi E
Endocr Relat Cancer; 2023 Oct; 30(10):. PubMed ID: 37493200
[TBL] [Abstract][Full Text] [Related]
47. Serum fatty acid profiling in patients with SDHx mutations: New advances on cellular metabolism in SDH deficiency.
Vamecq J; Masso V; Bancel LP; Jannin A; Dessein AF; Cardot-Bauters C; Pigny P
Biochimie; 2022 Oct; 201():196-203. PubMed ID: 35870552
[TBL] [Abstract][Full Text] [Related]
48. Paraganglioma and pheochromocytoma upon maternal transmission of SDHD mutations.
Bayley JP; Oldenburg RA; Nuk J; Hoekstra AS; van der Meer CA; Korpershoek E; McGillivray B; Corssmit EP; Dinjens WN; de Krijger RR; Devilee P; Jansen JC; Hes FJ
BMC Med Genet; 2014 Oct; 15():111. PubMed ID: 25300370
[TBL] [Abstract][Full Text] [Related]
49. A xenograft and cell line model of SDH-deficient pheochromocytoma derived from Sdhb+/- rats.
Powers JF; Cochran B; Baleja JD; Sikes HD; Pattison AD; Zhang X; Lomakin I; Shepard-Barry A; Pacak K; Moon SJ; Langford TF; Stein KT; Tothill RW; Ouyang Y; Tischler AS
Endocr Relat Cancer; 2020 Jun; 27(6):337-354. PubMed ID: 32252027
[TBL] [Abstract][Full Text] [Related]
50. Succinate-to-fumarate ratio as a new metabolic marker to detect the presence of SDHB/D-related paraganglioma: initial experimental and ex vivo findings.
Lendvai N; Pawlosky R; Bullova P; Eisenhofer G; Patocs A; Veech RL; Pacak K
Endocrinology; 2014 Jan; 155(1):27-32. PubMed ID: 24189137
[TBL] [Abstract][Full Text] [Related]
51. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.
Gill AJ; Benn DE; Chou A; Clarkson A; Muljono A; Meyer-Rochow GY; Richardson AL; Sidhu SB; Robinson BG; Clifton-Bligh RJ
Hum Pathol; 2010 Jun; 41(6):805-14. PubMed ID: 20236688
[TBL] [Abstract][Full Text] [Related]
52. Structural and functional consequences of succinate dehydrogenase subunit B mutations.
Kim E; Rath EM; Tsang VH; Duff AP; Robinson BG; Church WB; Benn DE; Dwight T; Clifton-Bligh RJ
Endocr Relat Cancer; 2015 Jun; 22(3):387-97. PubMed ID: 25972245
[TBL] [Abstract][Full Text] [Related]
53. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
[TBL] [Abstract][Full Text] [Related]
54. The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency.
Bayley JP; Devilee P; Taschner PE
BMC Med Genet; 2005 Nov; 6():39. PubMed ID: 16288654
[TBL] [Abstract][Full Text] [Related]
55. Succinate-Dehydrogenase Deficient Paragangliomas/Pheochromocytomas: Genetics, Clinical Aspects and Mini- Review.
Rusyn L; Kohn B
Pediatr Endocrinol Rev; 2017 Mar; 14(3):312-325. PubMed ID: 28508602
[No Abstract] [Full Text] [Related]
56. Sdhd and SDHD/H19 knockout mice do not develop paraganglioma or pheochromocytoma.
Bayley JP; van Minderhout I; Hogendoorn PC; Cornelisse CJ; van der Wal A; Prins FA; Teppema L; Dahan A; Devilee P; Taschner PE
PLoS One; 2009 Nov; 4(11):e7987. PubMed ID: 19956719
[TBL] [Abstract][Full Text] [Related]
57. Pathological mechanisms and parent-of-origin effects in hereditary paraganglioma/pheochromocytoma (PGL/PCC).
Müller U
Neurogenetics; 2011 Aug; 12(3):175-81. PubMed ID: 21547462
[TBL] [Abstract][Full Text] [Related]
58. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER
Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914
[TBL] [Abstract][Full Text] [Related]
59. Mutations of the SDHB and SDHD genes.
Pawlu C; Bausch B; Neumann HP
Fam Cancer; 2005; 4(1):49-54. PubMed ID: 15883710
[TBL] [Abstract][Full Text] [Related]
60. Succinate inhibition of alpha-ketoglutarate-dependent enzymes in a yeast model of paraganglioma.
Smith EH; Janknecht R; Maher LJ
Hum Mol Genet; 2007 Dec; 16(24):3136-48. PubMed ID: 17884808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
